1921
Volume 86, Issue 2
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645

Abstract

Abstract.

Dengue virus infections are a major cause of morbidity in tropical countries. Early detection of dengue hemorrhagic fever (DHF) may help identify individuals that would benefit from intensive therapy. Predictive modeling was performed using 11 laboratory values of 51 individuals (38 DF and 13 DHF) obtained on initial presentation using logistic regression. We produced a robust model with an area under the curve of 0.9615 that retained IL-10 levels, platelets, and lymphocytes as the major predictive features. A classification and regression tree was developed on these features that were 86% accurate on cross-validation. The IL-10 levels and platelet counts were also identified as the most informative features associated with DHF using a Random Forest classifier. In the presence of polymerase chain reaction-proven acute dengue infections, we suggest a complete blood count and rapid measurement of IL-10 can assist in the triage of potential DHF cases for close follow-up or clinical intervention improving clinical outcome.

Loading

Article metrics loading...

/content/journals/10.4269/ajtmh.2012.11-0469
2012-02-01
2017-11-21
Loading full text...

Full text loading...

/deliver/fulltext/14761645/86/2/341.html?itemId=/content/journals/10.4269/ajtmh.2012.11-0469&mimeType=html&fmt=ahah

References

  1. San Martin JL, Brathwaite O, Zambrano B, Solórzano JO, Bouckenooghe A, Dayan GH, Guzmán MG, , 2010. The epidemiology of dengue in the Americas over the last three decades: a worrisome reality. Am J Trop Med Hyg 82: 128135.[Crossref]
  2. Martina BE, Koraka P, Osterhaus AD, , 2009. Dengue virus pathogenesis: an integrated view. Clin Microbiol Rev 22: 564581.[Crossref]
  3. Graham RR, Juffrie M, Tan R, Hayes CG, Laksono I, Ma'roet C, Erlin, Sutaryo, Porter KR, Halstead SB, , 1999. A prospective seroepidemiologic study on dengue in children four to nine years of age in Yogyakarta, Indonesia I. studies in 1995–1996. Am J Trop Med Hyg 61: 412419.
  4. Guzman MG, Kouri G, Bravo J, Valdes L, Vazquez S, Halstead SB, , 2002. Effect of age on outcome of secondary dengue 2 infections. Int J Infect Dis 6: 118124.[Crossref]
  5. Thomas L, Verlaeten O, Cabie A, Kaidomar S, Moravie J, Najioullah F, Plumelle Y, Fonteau C, Dussart P, Césaire R, , 2008. Influence of the dengue serotype, previous dengue infection, and plasma viral load on clinical presentation and outcome during a dengue-2 and dengue-4 co-epidemic. Am J Trop Med Hyg 78: 990998.
  6. Kliks S, , 1990. Antibody-enhanced infection of monocytes as the pathogenetic mechanism for severe dengue illness. AIDS Res Hum Retroviruses 6: 993998.
  7. Green S, Rothman A, , 2006. Immunopathological mechanisms in dengue and dengue hemorrhagic fever. Curr Opin Infect Dis 19:: 429436.[Crossref]
  8. Rothman AL, , 2011. Immunity to dengue virus: a tale of original antigenic sin and tropical cytokine storms. Nat Rev Immunol 11: 532543.[Crossref]
  9. Ranjit S, Kissoon N, Jayakumar I, , 2005. Aggressive management of dengue shock syndrome may decrease mortality rate: a suggested protocol. Pediatr Crit Care Med 6: 6.[Crossref]
  10. Forshey BM, Guevara C, Laguna-Torres VA, Cespedes M, Vargas J, Gianella A, Vallego E, Madrid C, Aguayo N, Gotuzzo E, Suarez V, Morales AM, Beingolea L, Reyes N, Perez J, Negrete M, Rocha C, Morrison AC, Russell KL, Blair PS, , HMRCD Febrile Surveillance Working Group, 2010. Arboviral etiologies of acute febrile illnesses in western South America, 2000–2007. PLoS Negl Trop Dis 4: e787.[Crossref]
  11. Lanciotti RS, Calisher CH, Gubler DJ, Chang GJ, Vorndam AV, , 1992. Rapid detection and typing of dengue viruses from clinical samples by using reverse transcriptase-polymerase chain reaction. J Clin Microbiol 30: 545551.
  12. World Health Organization (WHO), 1997. Dengue Haemorrhagic Fever: Diagnosis, Treatment, and Control. Geneva: World Health Organization.
  13. Iswaharan H, Rao J, , 2005. Spike and slab variable selection: frequentist and Bayesian strategies. Ann Stat 33: 730773.[Crossref]
  14. Stone M, , 1977. An asymptotic equivalence of choice of model by cross-validation and Akaike's criterion. J R Stat Soc, B 39: 4447.
  15. Hassa PO, Hottiger MO, Burkle A, , 2006. PARP-1 as novel coactivator of NF-kB in inflammatory disorders. , ed. PolyADP Ribosylation. Austin, TX: Landes Bioscience, 7587.
  16. Fawcett T, , 2006. An introduction to ROC analysis. Pattern Recognit Lett 27: 861874.[Crossref]
  17. Hanley JA, McNeil BJ, , 1982. The meaning and use of the area under a receiver operating characteristic curve. Radiology 143: 2936.[Crossref]
  18. Potts JA, Gibbons RV, Rothman AL, Srikiatkhachorn A, Thomas SJ, Supradish PO, Lemon SC, Libraty DH, Green S, Kalayanarooj S, , 2010. Prediction of dengue disease severity among pediatric Thai patients using early clinical laboratory indicators. PLoS Negl Trop Dis 4: e769.[Crossref]
  19. Tanner L, Schreiber M, Low JG, Ong A, Tolfvenstam T, Lai YL, Ng LC, Leo YS, Thi Poung L, Vasudevan SG, Simmons CP, Hibberd ML, Ooi EE, , 2008. Decision tree algorithms predict the diagnosis and outcome of dengue fever in the early phase of illness. PLoS Negl Trop Dis 2: e196.[Crossref]
  20. Saraiva M, O'Garra A, , 2010. The regulation of IL-10 production by immune cells. Nat Rev Immunol 10: 170181.[Crossref]
  21. Boonnak K, Dambach KM, Donofrio GC, Tassaneetrithep B, Marovich MA, , 2011. Cell type specificity and host genetic polymorphisms influence antibody-dependent enhancement of dengue virus infection. J Virol 85: 16711683.[Crossref]
  22. Chareonsirisuthigul T, Kalayanarooj S, Ubol S, , 2007. Dengue virus (DENV) antibody-dependent enhancement of infection upregulates the production of anti-inflammatory cytokines, but suppresses anti-DENV free radical and pro-inflammatory cytokine production, in THP-1 cells. J Gen Virol 88: 365375.[Crossref]
  23. Bozza F, Cruz O, Zagne S, Azeredo EL, Nogueria RM, Assis EF, Bozza PT, Kubelka CF, , 2008. Multiplex cytokine profile from dengue patients: MIP-1beta and IFN-gamma as predictive factors for severity. BMC Infect Dis 8: 86.[Crossref]
  24. Chen LC, Lei HY, Liu CC, Shiesh SC, Chen SH, Liu HS, Lin YS, Wang ST, Shyu HW, Yeh TM, , 2006. Correlation of serum levels of macrophage migration inhibitory factor with disease severity and clinical outcome in dengue patients. Am J Trop Med Hyg 74: 142147.
  25. Chen RF, Yang KD, Wang L, Liu JW, Chiu CC, Cheng JT, , 2007. Different clinical and laboratory manifestations between dengue hemorrhagic fever and dengue fever with bleeding tendency. Trans R Soc Trop Med Hyg 101: 11061113.[Crossref]
  26. Perez AB, Garcia G, Sierra B, Alvarez M, Vázquez S, Cabrera MV, Rodriguez R, Rosario D, Martinez E, Denny T, Guzmán MG, , 2004. IL-10 levels in dengue patients: some findings from the exceptional epidemiological conditions in Cuba. J Med Virol 73: 230234.[Crossref]
  27. Mitrakul C, Poshyachinda M, Futrakul P, Sangkawibha N, Ahandrik S, , 1977. Hemostatic and platelet kinetic studies in dengue hemorrhagic fever. Am J Trop Med Hyg 26: 975984.
  28. Eu-Ahsunthornwattana N, Eu-ahsunthornwattana J, Thisyakorn U, , 2008. Peripheral blood count for dengue severity prediction: a prospective study in Thai children. Pediatrics 121: S127S128.[Crossref]
http://instance.metastore.ingenta.com/content/journals/10.4269/ajtmh.2012.11-0469
Loading
/content/journals/10.4269/ajtmh.2012.11-0469
Loading

Data & Media loading...

  • Received : 19 Jul 2011
  • Accepted : 18 Nov 2011

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error